Dr Megg Spriggs completed her PhD in psychology at the University of Auckland, New Zealand in 2018. Megg joined the Centre for Psychedelic Research in 2019, working as a trial coordinator and guide on trials of psilocybin. Her main role is one of the lead researchers on the Centre’s upcoming clinical trial assessing psilocybin-assisted psychotherapy as a treatment for anorexia nervosa.
Colloquium Presentation: 19 November 2021
Electrophysiological Markers of Neuroplasticity: A Novel Approach for Psychedelics.